The National Institutes of Health believes that the U.S. is missing out on important scientific discoveries in smaller states such as Maine because they lack the resources to move those discoveries out of laboratories and into the marketplace.
It recently awarded a $3.5 million grant to create a technology transfer accelerator program for biotech startups in Maine, Vermont, Rhode Island, Delaware and New Hampshire. The goal is to spur development and commercialization of human health-focused bioscience discoveries in those states.
Image: https://www.centralmaine.com - Kevin Strange
